{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:23:53Z","timestamp":1792038233225,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd011611.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T00:00:00Z","timestamp":1633651200000}}],"reference-count":141,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011611.pub3","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T09:47:14Z","timestamp":1633859234000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder"],"prefix":"10.1002","volume":"2021","author":[{"given":"Rebecca L","family":"Dean","sequence":"additional","affiliation":[{"name":"Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahnee","family":"Marquardt","sequence":"additional","affiliation":[{"name":"Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Hurducas","sequence":"additional","affiliation":[{"name":"Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Styliani","family":"Spyridi","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Sciences, Faculty of Health Sciences; Cyprus University of Technology; Lemesos Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle","family":"Barnes","sequence":"additional","affiliation":[{"name":"Oxford Health NHS Foundation Trust; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Smith","sequence":"additional","affiliation":[{"name":"UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J","family":"Cowen","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; University of Oxford; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupert","family":"McShane","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; University of Oxford; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Hawton","sequence":"additional","affiliation":[{"name":"Centre for Suicide Research, University Department of Psychiatry; Warneford Hospital; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gin S","family":"Malhi","sequence":"additional","affiliation":[{"name":"Discipline of Psychiatry, Northern Clinical School; University of Sydney; Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Geddes","sequence":"additional","affiliation":[{"name":"UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cipriani","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; University of Oxford; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,10,8]]},"reference":[{"key":"10.1002\/14651858.CD011611.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1399-5618.2011.00971.x","article-title":"Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double-blind, randomized, placebo-controlled trial","volume":"14","author":"Anand","year":"2012","journal-title":"Bipolar Disorders"},{"issue":"1","key":"10.1002\/14651858.CD011611.pub3-BIB0002|cit2","first-page":"18m12200","article-title":"A double-blind, randomized, placebo-controlled study of aspirin and N-Acetylcysteine as adjunctive treatments for bipolar depression","volume":"80","author":"Bauer","year":"2019","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD011611.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12916-019-1257-1","article-title":"A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo","volume":"17","author":"Berk","year":"2019","journal-title":"BMC Medicine"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","article-title":"A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression","volume":"67","author":"Diazgranados","year":"2010","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1038\/tp.2014.105","article-title":"Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression","volume":"4","author":"Lally","year":"2014","journal-title":"Translational Psychiatry"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jad.2018.10.083","article-title":"The efficacy of adjunctive N-acetylcysteine in acute bipolar depression: a randomized placebo-controlled study","volume":"245","author":"Ellegard","year":"2019","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/bdi.12487","article-title":"Ketamine versus midazolam in bipolar depression with suicidal thoughts: a pilot midazolam-controlled randomized clinical trial","volume":"19","author":"Grunebaum","journal-title":"Bipolar Disorders"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/JCP.0000000000000109","article-title":"The effects of add-on low-dose memantine on cytokine levels in bipolar II depression: a 12-week double-blind, randomized controlled trial","volume":"34","author":"Lee","year":"2014","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD011611.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/JCP.0000000000000693","article-title":"A double-blind, placebo-controlled, pilot study of riluzole monotherapy for acute bipolar depression","volume":"37","author":"Park","year":"2017","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"7","key":"10.1002\/14651858.CD011611.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1038\/npp.2009.2","article-title":"Decreased glutamate\/glutamine levels may mediate cytidine's efficacy in treating bipolar depression: a longitudinal proton magnetic resonance spectroscopy study","volume":"34","author":"Yoon","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1038\/tp.2014.105","article-title":"Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression","volume":"4","author":"Lally","year":"2014","journal-title":"Translational Psychiatry"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","article-title":"Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial","volume":"71","author":"Zarate","year":"2012","journal-title":"Biological Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD011611.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1192\/bjp.bp.115.173930","article-title":"Methylene blue treatment for residual symptoms of bipolar disorder: randomised crossover study","volume":"210","author":"Alda","year":"2017","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD011611.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.pnpbp.2011.11.011","article-title":"Systemic illness moderates the impact of N-acetyl cysteine in bipolar disorder","volume":"37","author":"\u00a0Magalh\u00e3es","year":"2012","journal-title":"Progress in Neuropsychopharmacology and Biological Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD011611.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.biopsych.2008.04.022","article-title":"N-acetyl cysteine for depressive symptoms in bipolar disorder-a double-blind randomized placebo-controlled trial","volume":"64","author":"Berk","year":"2008","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0016|cit16","unstructured":"Dean O Berk M Cotton SM Bush AI Gama CS Kapczinski F N-acetyl cysteine (NAC) as an adjunctive therapy for bipolar depression conference poster P35 Bipolar disorders. Abstracts of the 9th International Conference on Bipolar Disorder; 2011 June 9-11 Pittsburgh [PA] 2011 38"},{"issue":"5","key":"10.1002\/14651858.CD011611.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1601-5215.2010.00472.x","article-title":"The validity and internal structure of the Bipolar Depression Rating Scale: data from a clinical trial of N-acetylcysteine as adjunctive therapy in bipolar disorder","volume":"22","author":"Berk","year":"2010","journal-title":"Acta Neuropsychiatrica"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0018|cit18","first-page":"S176","article-title":"Celecoxib augmentation of escitalopram in treatment-resistant bipolar depression: effects on trycats","volume":"43","author":"Castillo","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"10.1002\/14651858.CD011611.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.euroneuro.2014.09.001","article-title":"Therapeutic effects of add-on low-dose dextromethorphan plus valproic acid in bipolar disorder","volume":"24","author":"Chen","year":"2014","journal-title":"European Neuropsychopharmacology"},{"issue":"33","key":"10.1002\/14651858.CD011611.pub3-BIB0020|cit20","first-page":"2309","article-title":"Acupunctura, \"vital\" drugs and psychopharmacological agents in the treatment of psychiatric patients with deep depressive disorders, with considerations on the probable neurophysiological mechanisms of the synergism of action [article in Italian]","volume":"68","author":"Cocchi","year":"1977","journal-title":"Minerva Medica"},{"issue":"5","key":"10.1002\/14651858.CD011611.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1176\/ajp.135.5.562","article-title":"Dose-related biphasic effect of prolyl-leucyl-glycinamide (MIF-I) in depression","volume":"135","author":"Ehrensing","year":"1978","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0022|cit22","first-page":"127S","article-title":"Effects of ketamine versus scopolamine on individual depression and anxiety symptoms (abstract)","volume":"75","author":"Ellis","year":"2014","journal-title":"Biological Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD011611.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"737","DOI":"10.4088\/JCP.14l09527","article-title":"Single-dose ketamine followed by daily D-Cycloserine in treatment-resistant bipolar depression","volume":"76","author":"Kantrowitz","year":"2015","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jad.2012.01.024","article-title":"The DRD2\/ANKK1 gene is associated with response to add-on dextromethorphan treatment in bipolar disorder","volume":"138","author":"Lee","year":"2012","journal-title":"Journal of Affective Disorders"},{"issue":"1","key":"10.1002\/14651858.CD011611.pub3-BIB0025|cit25","first-page":"94","article-title":"The COMT Val158Met Polymorphism is associated with response to add-on dextromethorphan treatment in bipolar disorder","volume":"37","author":"Lee","year":"2017","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jad.2014.02.017","article-title":"Do the dissociative side effects of ketamine mediate its antidepressant effects?","volume":"159","author":"Luckenbaugh","year":"2014","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0027|cit27","unstructured":"A double blind, placebo controlled, randomised trial to evaluate the effect of mitochondrial agents, N-acetyl cysteine or placebo on the depressive phase of bipolar disorder www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?ACTRN=12612000830897"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0028|cit28","unstructured":"Ketamine augmentation of ECT to improve outcomes in depression www.isrctn.org\/ISRCTN14689382"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0029|cit29","unstructured":"Comparing therapeutic efficacy and cognitive side effects of electroconvulsive therapy (ECT) using ketamine versus methohexital anesthesia www.clinicaltrials.gov\/show\/NCT01881763"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0030|cit30","unstructured":"\u00a0NRX-101 for maintenance of remission from severe bipolar depression in patients with suicidal ideation ClinicalTrials.gov\/show\/NCT03396068"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0031|cit31","unstructured":"NRX100 vs. placebo for rapid stabilization of acute suicidal ideation and behavior in bipolar depression (SevereBD) ClinicalTrials.gov\/show\/NCT03396601"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0032|cit32","doi-asserted-by":"crossref","unstructured":"Abdallah C Averill LA Gueorguieva R Goktas S Purohit P Ranganathan M Rapamycin, an immunosuppressant and mTORC1 inhibitor, triples the antidepressant response rate of ketamine at 2 weeks following treatment: a double-blind, placebo-controlled, cross-over, randomized clinical trial bioRxiv 2018","DOI":"10.1101\/500959"},{"issue":"2","key":"10.1002\/14651858.CD011611.pub3-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.rpsm.2016.05.005","article-title":"Efficacy and safety of ketamine in bipolar depression: a systematic review","volume":"10","author":"Alberich","year":"2017","journal-title":"Revista de Psiquiatr\u00eda y Salud Mental"},{"issue":"7066","key":"10.1002\/14651858.CD011611.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0035|cit35","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1980"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0036|cit36","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1987"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0037|cit37","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0038|cit38","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890423349","volume-title":"Diagnostic and Statistical Manual of Mental Disorders - Text Revision (DSM-IV-TR)","author":"American Psychiatric Association","year":"2000"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0039|cit39","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"issue":"3","key":"10.1002\/14651858.CD011611.pub3-BIB0040|cit40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007954","article-title":"Antidepressants versus placebo for depression in primary care","author":"Arroll","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7454","key":"10.1002\/14651858.CD011611.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"issue":"9","key":"10.1002\/14651858.CD011611.pub3-BIB0042|cit42","first-page":"1428-34","article-title":"What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?","volume":"67","author":"Bandelow","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jpsychires.2014.04.017","article-title":"Inflammatory mediators of cognitive impairment in bipolar disorder","volume":"56","author":"Bauer","year":"2014","journal-title":"Journal of Psychiatric Research"},{"issue":"2","key":"10.1002\/14651858.CD011611.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"137-51","DOI":"10.1038\/nrn1846","article-title":"New approaches to antidepressant drug discovery: beyond monoamines","volume":"7","author":"Berton","year":"2006","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0045|cit45","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-021-01093-2","article-title":"Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability","volume":"15 April","author":"Bonaventura","year":"2021","journal-title":"Molecular Psychiatry"},{"issue":"33","key":"10.1002\/14651858.CD011611.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1-56","DOI":"10.3310\/hta5330","article-title":"Subgroup analyses in randomized controlled trials: quantifying the risks of false-positives and false-negatives","volume":"5","author":"Brookes","year":"2001","journal-title":"Health Technology Assessment"},{"issue":"3","key":"10.1002\/14651858.CD011611.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jclinepi.2003.08.009","article-title":"Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test","volume":"57","author":"Brookes","year":"2004","journal-title":"Journal of Clinical Epidemiology"},{"issue":"9","key":"10.1002\/14651858.CD011611.pub3-BIB0048|cit48","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011612.pub2","article-title":"Ketamine and other glutamate receptor modulators for depression in adults","author":"Caddy","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD011611.pub3-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"1348-63","DOI":"10.1016\/j.euroneuro.2013.07.007","article-title":"A systematic review and meta-analysis of proton magnetic resonance spectroscopy and mismatch negativity in bipolar disorder","volume":"23","author":"Chitty","year":"2013","journal-title":"European Neuropsychopharmacology"},{"issue":"9665","key":"10.1002\/14651858.CD011611.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"746-58","DOI":"10.1016\/S0140-6736(09)60046-5","article-title":"Efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis","volume":"373","author":"Cipriani","year":"2009","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD011611.pub3-BIB0051|cit51","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006117.pub4","article-title":"Sertraline versus other antidepressive agents for depression","author":"Cipriani","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD011611.pub3-BIB0052|cit52","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006534.pub2","article-title":"Citalopram versus other anti-depressive agents for depression","author":"Cipriani","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"f3646","DOI":"10.1136\/bmj.f3646","article-title":"Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis","volume":"346","author":"Cipriani","year":"2013","journal-title":"BMJ"},{"issue":"10","key":"10.1002\/14651858.CD011611.pub3-BIB0054|cit54","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006533.pub2","article-title":"Duloxetine versus other anti-depressive agents for depression","author":"Cipriani","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10228","key":"10.1002\/14651858.CD011611.pub3-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S0140-6736(19)33177-0","article-title":"Generating comparative evidence on new drugs and devices after approval","volume":"395","author":"Cipriani","year":"2020","journal-title":"Lancet"},{"issue":"12","key":"10.1002\/14651858.CD011611.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1001\/jamapsychiatry.2019.3012","article-title":"Evidence-based drug treatment of acute depression in bipolar disorder","volume":"76","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD011611.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/hup.2475","article-title":"The use of ketamine as an antidepressant: a systematic review and meta-analysis","volume":"30","author":"Coyle","year":"2015","journal-title":"Human Psychopharmacology: Clinical and Experimental"},{"issue":"11","key":"10.1002\/14651858.CD011611.pub3-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1016\/s0028-3908(00)00051-4","article-title":"The anticonvulsant, lamotrigine decreases spontaneous glutamate release but increases spontaneous GABA release in the rat entorhinal cortex in vitro","volume":"39","author":"Cunningham","year":"2000","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1002\/14651858.CD011611.pub3-BIB0059|cit59","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011612.pub3","article-title":"Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder","author":"Dean","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0060|cit60","first-page":"259","volume-title":"Handbook of Assessment and Treatment Planning for Psychological Disorders","author":"Dozois","year":"2004"},{"issue":"3","key":"10.1002\/14651858.CD011611.pub3-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/ebmental-2019-300103","article-title":"Statistics in pills: meta-analysis of rare events","volume":"22","author":"Efthimiou","year":"2019","journal-title":"Evidence Based Mental Health"},{"issue":"7109","key":"10.1002\/14651858.CD011611.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"629-34","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD011611.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"140-9","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving crossover trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD011611.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"57-63","DOI":"10.1001\/archpsyc.1972.01750190059011","article-title":"Diagnostic criteria for use in psychiatric research","volume":"26","author":"Feighner","year":"1972","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD011611.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"72-6","DOI":"10.1093\/ije\/31.1.72","article-title":"An empirical study of summary effect measures in meta-analyses","volume":"31","author":"Furukawa","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD011611.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"49-52","DOI":"10.1097\/00004850-200501000-00010","article-title":"Imputing response rates from means and standard deviations in meta-analysis","volume":"20","author":"Furukawa","year":"2005","journal-title":"International Clinical Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD011611.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"7-10","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD011611.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"468-70","DOI":"10.1001\/jama.297.5.468-b","article-title":"Association between unreported outcomes and effect size estimates in Cochrane meta-analyses","volume":"297","author":"Furukawa","year":"2007","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD011611.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"531-4","DOI":"10.1097\/JCP.0b013e31814f30b1","article-title":"Evidence-based guidelines for interpretation of the Hamilton Rating Scale for Depression","volume":"27","author":"Furukawa","year":"2007","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"9878","key":"10.1002\/14651858.CD011611.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0140-6736(13)60857-0","article-title":"Treatment of bipolar disorder","volume":"381","author":"Geddes","year":"2013","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1399-5618.2012.01033.x","article-title":"Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis","volume":"14","author":"Gigante","year":"2012","journal-title":"Bipolar Disorders"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jad.2018.12.092","article-title":"Changes in brain Glx in depressed bipolar patients treated with lamotrigine: a proton MRS study","volume":"246","author":"Godlewska","year":"2019","journal-title":"Journal of Affective Disorders"},{"issue":"6","key":"10.1002\/14651858.CD011611.pub3-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1177\/0269881116636545","article-title":"Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology","volume":"30","author":"Goodwin","year":"2016","journal-title":"Journal of Psychopharmacology"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0074|cit74","unstructured":"McMaster University (developed by Evidence Prime, Inc.) GRADEproGDT: GRADEpro Guideline Development Tool [www.guidelinedevelopment.org]"},{"issue":"1","key":"10.1002\/14651858.CD011611.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"16","DOI":"10.9740\/mhc.2017.01.016","article-title":"Ketamine for the treatment of major depressive disorder andbipolar depression: a review of the literature","volume":"7","author":"Tenhouse","year":"2017","journal-title":"Mental Health Clinician"},{"issue":"12","key":"10.1002\/14651858.CD011611.pub3-BIB0076|cit76","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006815.pub2","article-title":"Hydroxyzine for generalised anxiety disorder","author":"Guaiana","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0077|cit77","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"issue":"7132","key":"10.1002\/14651858.CD011611.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"690-3","DOI":"10.1136\/bmj.316.7132.690","article-title":"Interpreting treatment effects in randomised trials","volume":"316","author":"Guyatt","year":"1998","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD011611.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1192\/bjp.2018.257","article-title":"Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definition","volume":"214","author":"Hidalgo-Mazzei","year":"2019","journal-title":"British Journal of Psychiatry"},{"issue":"7414","key":"10.1002\/14651858.CD011611.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"557-60","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0082|cit82","unstructured":"Higgins JP Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0083|cit83","unstructured":"Higgins JP Altman DG Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0084|cit84","unstructured":"Higgins JP Deeks JJ Chapter 16: Special topics in statistics. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0085|cit85","unstructured":"Higgins JP Chapter 7: Selecting studies and collecting data. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"2037-44","DOI":"10.1038\/sj.npp.1300272","article-title":"Subdissociative dose ketamine produces a deficit in manipulation but not maintenance of the contents of working memory","volume":"28","author":"Honey","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD011611.pub3-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1136\/ebmental-2020-300207","article-title":"Prevalence of bipolar disorder in multiple sclerosis: a systematic review and meta-analysis","volume":"24","author":"Joseph","year":"2021","journal-title":"Evidence-Based Mental Health"},{"issue":"6","key":"10.1002\/14651858.CD011611.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.59.6.530","article-title":"The long-term natural history of the weekly symptomatic status of bipolar I disorder","volume":"59","author":"Judd","year":"2002","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD011611.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/archpsyc.60.3.261","article-title":"A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder","volume":"60","author":"Judd","year":"2003","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"g5673","DOI":"10.1136\/bmj.g5673","article-title":"Assessment and management of bipolar disorder: summary of updated NICE guidance","volume":"349","author":"Kendall","year":"2014","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD011611.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/13651501.2016.1254802","article-title":"Administration of ketamine for unipolar and bipolar depression","volume":"21","author":"Kraus","year":"2017","journal-title":"International Journal of Psychiatry in Clinical Practice"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s43440-020-00097-z","article-title":"Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials","volume":"72","author":"Kryst","year":"2020","journal-title":"Pharmacological Reports"},{"issue":"10","key":"10.1002\/14651858.CD011611.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"e76882","DOI":"10.1371\/journal.pone.0076882","article-title":"Characterization of treatment resistant depression episodes in a cohort of patients from a US commercial claims database","volume":"8","author":"Kubitz","year":"2013","journal-title":"PLOS One"},{"issue":"5994","key":"10.1002\/14651858.CD011611.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3389\/fpsyt.2018.00767","article-title":"Glutamatergic dysfunction and glutamatergic compounds for major psychiatric disorders: evidence from clinical neuroimaging studies","volume":"9","author":"Li","year":"2018","journal-title":"Frontiers in Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD011611.pub3-BIB0096|cit96","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004185.pub2","article-title":"Fluoxetine versus other types of pharmacotherapy for depression","author":"Magni","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0097|cit97","first-page":"e5","article-title":"Ketamine: stimulating antidepressant treatment?","volume":"11","author":"Malhi","year":"2016","journal-title":"BJ Psych Open"},{"issue":"4","key":"10.1002\/14651858.CD011611.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/bdi.12622","article-title":"Modeling suicide in bipolar disorders","volume":"20","author":"Malhi","year":"2018","journal-title":"Bipolar Disorders"},{"issue":"8","key":"10.1002\/14651858.CD011611.pub3-BIB0099|cit99","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/bdi.13036","article-title":"The 2020 Royal Australian and New Zealand College of psychiatrists clinical practice guidelines for mood disorders: bipolar disorder summary","volume":"22","author":"Malhi","year":"2020","journal-title":"Bipolar Disorders"},{"issue":"8","key":"10.1002\/14651858.CD011611.pub3-BIB0100|cit100","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/bdi.13035","article-title":"The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: major depression summary","volume":"22","author":"Malhi","year":"2020","journal-title":"Bipolar Disorders"},{"issue":"9","key":"10.1002\/14651858.CD011611.pub3-BIB0101|cit101","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1177\/00048674211010233","article-title":"The 2020 mood disorders clinical practice guidelines: translating evidence into practice with both style and substance","volume":"55","author":"Malhi","year":"2020","journal-title":"Australian & New Zealand Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD011611.pub3-BIB0102|cit102","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/0004867420979353","article-title":"The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders","volume":"55","author":"Malhi","year":"2021","journal-title":"Australian & New Zealand Journal of Psychiatry"},{"issue":"10265","key":"10.1002\/14651858.CD011611.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0140-6736(20)31544-0","article-title":"Bipolar Disorders","volume":"396","author":"McIntyre","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD011611.pub3-BIB0104|cit104","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1007\/s12325-021-01732-8","article-title":"Strategies to prolong ketamine's efficacy in adults with treatment-resistant depression","volume":"38","author":"McMullen","year":"2021","journal-title":"Advances in Therapy"},{"issue":"3","key":"10.1002\/14651858.CD011611.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the World Mental Health Survey Initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Archives of General Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD011611.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1192\/bjp.bp.110.088823","article-title":"Comparison of depressive episodes in bipolar disorder and in major depressive disorder within bipolar disorder pedigrees","volume":"199","author":"Mitchell","year":"2011","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"382-9","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1360-0443.2009.02761.x","article-title":"Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study","volume":"105","author":"Morgan","year":"2010","journal-title":"Addiction"},{"issue":"7","key":"10.1002\/14651858.CD011611.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/s41380-018-0252-9","article-title":"Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies.","volume":"24","author":"Moriguchi","year":"2019","journal-title":"Molecular Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD011611.pub3-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"255-60","DOI":"10.1016\/S0165-0327(02)00120-9","article-title":"Differentiating moderate and severe depression using the Montgomery-Asberg depression rating scale (MADRS)","volume":"77","author":"Muller","year":"2003","journal-title":"Journal of Affective Disorders"},{"issue":"9947","key":"10.1002\/14651858.CD011611.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(14)60844-8","article-title":"Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"384","author":"Murray","year":"2014","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jad.2013.11.014","article-title":"A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action","volume":"156","author":"Naughton","year":"2014","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev-pharmtox-011613-135950","article-title":"Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds","volume":"54","author":"Niciu","year":"2014","journal-title":"Annual Review of Pharmacology and Toxicology"},{"issue":"2","key":"10.1002\/14651858.CD011611.pub3-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.biopsych.2008.09.029","article-title":"Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist","volume":"65","author":"Phelps","year":"2009","journal-title":"Biological Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD011611.pub3-BIB0116|cit116","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/bdi.12087","article-title":"Epidemiology of suicide in bipolar disorders: a systematic review of the literature","volume":"15","author":"Pompili","year":"2013","journal-title":"Bipolar Disorders"},{"issue":"4","key":"10.1002\/14651858.CD011611.pub3-BIB0117|cit117","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006531.pub2","article-title":"Paroxetine versus other anti-depressive agents for depression","author":"Purgato","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0118|cit118","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"11","key":"10.1002\/14651858.CD011611.pub3-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.4088\/JCP.09r05259gre","article-title":"The neurobiology of the switch process in bipolar disorder: a review","volume":"71","author":"Salvadore","year":"2010","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD011611.pub3-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/eb-2016-102355","article-title":"Ketamine for treatment-resistant depression: recent developments and clinical applications.","volume":"19","author":"Schwartz","year":"2016","journal-title":"Evidence-Based Mental Health."},{"issue":"6","key":"10.1002\/14651858.CD011611.pub3-BIB0121|cit121","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/bdi.12683","article-title":"Modelling suicide in bipolar disorders: Limitations and opportunities","volume":"20","author":"Smith","year":"2018","journal-title":"Bipolar Disorders"},{"issue":"6","key":"10.1002\/14651858.CD011611.pub3-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"773-82","DOI":"10.1001\/archpsyc.1978.01770300115013","article-title":"Research diagnostic criteria: rationale and reliability","volume":"35","author":"Spitzer","year":"1978","journal-title":"Archives of General Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD011611.pub3-BIB0123|cit123","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1136\/ebmental-2020-300148","article-title":"Daily self-reported and automatically generated smartphone-based sleep measurements in patients with newly diagnosed bipolar disorder, unaffected first-degree relatives and healthy control individuals","volume":"23","author":"Stanislaus","year":"2020","journal-title":"Evidence-Based Mental Health"},{"issue":"11","key":"10.1002\/14651858.CD011611.pub3-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"1119-29","DOI":"10.1016\/S0895-4356(00)00242-0","article-title":"Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature","volume":"53","author":"Sterne","year":"2000","journal-title":"Journal of Clinical Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD011611.pub3-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"1051-63","DOI":"10.1017\/S0033291797005205","article-title":"Symptom profiles of depression among general medical service users compared with specialty mental health service users","volume":"27","author":"Suh","year":"1997","journal-title":"Psychological Medicine"},{"issue":"6","key":"10.1002\/14651858.CD011611.pub3-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/acps.12343","article-title":"Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis","volume":"130","author":"Taylor","year":"2014","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD011611.pub3-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3109\/09638230903469269","article-title":"Systematic review of lamotrigine augmentation of treatment resistant unipolar depression (TRD)","volume":"19","author":"Thomas","year":"2010","journal-title":"Journal of Mental Health"},{"issue":"1","key":"10.1002\/14651858.CD011611.pub3-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12264-014-1484-6","article-title":"Rapid-onset antidepressant efficacy of glutamatergic system modulators: the neural plasticity hypothesis of depression","volume":"31","author":"Wang","year":"2015","journal-title":"Neuroscience Bulletin"},{"issue":"6","key":"10.1002\/14651858.CD011611.pub3-BIB0129|cit129","first-page":"473-83","article-title":"The MOS 36-item short form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Sherbourne","year":"1992","journal-title":"Medical Care"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0130|cit130","volume-title":"SF-12: How to Score the SF-12. Physical and Mental Health Summary Scales","author":"Ware","year":"1998"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0131|cit131","volume-title":"The ICD-10 Classification of Mental and Behavioural Disorders","author":"World Health Organization (WHO)","year":"1992"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0132|cit132","unstructured":"World Health Organization (WHO) International statistical classification of diseases and related health problems (11th Revision) Retrieved from https:\/\/icd.who.int\/browse11\/l-m\/en"},{"issue":"12","key":"10.1002\/14651858.CD011611.pub3-BIB0133|cit133","first-page":"1569-85","article-title":"The World Health Organization quality of life assessment (WHOQOL): Development and general psychometric properties","volume":"46","author":"WHOQOL Group","year":"1998","journal-title":"Social Science and Medicine"},{"issue":"2","key":"10.1002\/14651858.CD011611.pub3-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.drudis.2018.11.007","article-title":"A new generation of antidepressants: an update on the pharmaceutical pipeline for novel and rapid-acting therapeutics in mood disorders based on glutamate\/GABA neurotransmitter systems","volume":"24","author":"Wilkinson","year":"2019","journal-title":"Drug Discovery Today"},{"issue":"12","key":"10.1002\/14651858.CD011611.pub3-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1176\/appi.ajp.2018.18020138","article-title":"Attenuation of antidepressant effects of ketamine by opioid receptor antagonism.","volume":"175","author":"Williams","year":"2018","journal-title":"American Journal of Psychiatry."},{"key":"10.1002\/14651858.CD011611.pub3-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1192\/bjp.172.1.11","article-title":"Health of the nation outcome scales (HoNOS). Research and development","volume":"172","author":"Wing","year":"1998","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD011611.pub3-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/0004867419883341","article-title":"Ketamine for suicidal ideation in adults with psychiatric disorders: A systematic review and meta-analysis of treatment trials.","volume":"54","author":"Witt","year":"2020","journal-title":"Australian and New Zealand JournL of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD011611.pub3-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1176\/appi.ajp.163.1.153","article-title":"A double-blind, placebo-controlled study of memantine in the treatment of major depression","volume":"163","author":"Singh","year":"2006","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD011611.pub3-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11126-012-9208-4","article-title":"Lamotrigine in the treatment of unipolar depression with and without comorbidities: a literature review","volume":"83","author":"Zavodnick","year":"2012","journal-title":"Psychiatric Quarterly"},{"issue":"9","key":"10.1002\/14651858.CD011611.pub3-BIB0140|cit140","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011611.pub2","article-title":"Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults","author":"McCloud","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD011611.pub3-BIB0141|cit141","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011611","article-title":"Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults","author":"Rendell","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T03:19:04Z","timestamp":1669864744000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011611.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Common Mental Disorders Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,10,8]]},"references-count":141,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011611.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,8]]}}}